7 completed. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 7 |
Follow Enuresis: new trials by email Literature Review of Enuresis trials Research Report on Enuresis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings. Desmopressin, Conditional alarm - Enuresis, Nocturnal | Phase 4 | Completed | University of Aarhus | 324 | 2017-10-01 | 2023-08-02 |
| Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders Coloverin, Placebo - Oncology, Incontinence | Phase 4 | Completed | Mansoura University | 110 | 2017-05-15 | 2020-06-30 |
| A New Check-list Method for Nocturnal Enuresis desmopressin melt form 120 μg, Verbal behavioral therapy, Behavioral therapy with written check-list - Nocturnal Enuresis | Phase 4 | Completed | Ankara Training and Research Hospital | 75 | 2015-01-01 | 2018-05-01 |
| Desmopressin Melt: Impact on Sleep and Daytime Functioning Desmopressin lyophilisate (Melt) - Monosymptomatic Nocturnal Enuresis | Phase 4 | Completed | University Hospital, Ghent | 30 | 2011-04-01 | 2022-12-15 |
| Influence of Food-intake on Desmopressin Oral Tablets and MELT-formulation desmopressin tablet, desmopressin MELT formulation - Enuresis, Polyuria | Phase 4 | Completed | University Hospital, Ghent | 24 | 2009-12-01 | 2019-02-06 |
| The Effect of Indomethacin in Monosymptomatic Enuresis Nocturnal Indomethacin - Enuresis | Phase 4 | Completed | University of Aarhus | 56 | 2003-01-01 | 2010-06-25 |
| A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis Primary nocturnal enuresis - Nocturnal Enuresis | Phase 4 | Completed | Ferring Pharmaceuticals | 802 | 2002-04-01 | 2011-05-19 |
Nocturnal Enuresis (4) · Diurnal Enuresis (1) · Neoplasms (1) · Patient Compliance (1) · Polyuria (1) · Urinary Bladder Neoplasms (1)
Behavior (7) · Behavioral Symptoms (7) · Elimination Disorders (7) · Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Male Urogenital Diseases (7) · Mental Disorders (7) · Urination Disorders (7) · Urogenital Diseases (7) · Urologic Diseases (7) · Health Behavior (1) · Neoplasms by Site (1) · Pathological Conditions, Signs and Symptoms (1) · Patient Acceptance of Health Care (1)
Deamino Arginine Vasopressin (2) · Freezing (2) · Behavior Therapy (1) · Indomethacin (1) · mebeverine (1)
University Hospital, Ghent (2) · University of Aarhus (2) · Ankara Training and Research Hospital (1) · Ferring Pharmaceuticals (1) · Mansoura University (1)
Belgium (3) · Denmark (2) · China (1) · Egypt (1) · France (1) · Poland (1) · Turkey (Türkiye) (1)
Johan Vande Walle, MD, PhD (2) · Ahmed Elhussein, MBBCH (1) · Ahmed Elkarta, MBBCH (1) · Ahmed Mosbah, MD (1) · Ahmet M Hascicek, M.D. (1) · Hassan Abol-Enein, MD (1) · Konstantinos Kamperis, MD. PhD (1) · Mohamed Soltan, MBBCH (1)
PMID 40728007, PMID 19125991, PMID 23881652, PMID 25504157, PMID 26059526, PMID 27067081, PMID 27787700, PMID 28888814, PMID 38950376